Investor Relations We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology. Email Alerts Investors: Overview Press Releases Events and Presentations Financials & Filings Stock Information Investor FAQs Contact Us Events Presentations Canaccord Genuity 37th Annual Growth Conference Wednesday, August 9, 2017 12:30pm EDT Listen to the Webcast